ML15258A389

Shine Medical Technologies V. 0 - PSAR Master Table of Contents

ML15258A389
Person / Time
Site:	SHINE Medical Technologies
Issue date:	08/27/2015
From:	Bynum R Shine Medical Technologies
To:	Office of Nuclear Reactor Regulation
Lynch S
References
SHINE, SHINE.SUBMISSION.22, SHN.PSAR.P, SHN.PSAR.P.10
Download: ML15258A389 (6)

Text

Preliminary Safety Analysis Report Master Table of Contents Master Table of Contents Section Title Page CHAPTER 1 THE FACILITY

1.1 INTRODUCTION

..................................................................................................... 1-1 1.2

SUMMARY

AND CONCLUSIONS ON PRINCIPAL SAFETY CONSIDERATIONS................................................................................................. 1-2 1.3 GENERAL DESCRIPTION OF THE FACILITY ....................................................... 1-8 1.4 SHARED FACILITIES AND EQUIPMENT............................................................... 1-13 1.5 COMPARISON WITH SIMILAR FACILITIES........................................................... 1-14 1.6

SUMMARY

OF OPERATIONS ................................................................................ 1-18 1.7 COMPLIANCE WITH THE NUCLEAR WASTE POLICY ACT OF 1982 ................. 1-19 1.8 FACILITY MODIFICATIONS AND HISTORY.......................................................... 1-20

1.9 REFERENCES

........................................................................................................ 1-21 CHAPTER 2 SITE CHARACTERISTICS 2.1 GEOGRAPHY AND DEMOGRAPHY ...................................................................... 2.1-1 2.2 NEARBY INDUSTRIAL, TRANSPORTATION, AND MILITARY FACILITIES.............................................................................................................. 2.2-1 2.3 METEOROLOGY..................................................................................................... 2.3-1 2.4 HYDROLOGY.......................................................................................................... 2.4-1 2.5 GEOLOGY, SEISMOLOGY, AND GEOTECHNICAL ENGINEERING.................... 2.5-1

2.6 REFERENCES

........................................................................................................ 2.6-1 CHAPTER 3 DESIGN OF STRUCTURES, SYSTEMS, AND COMPONENTS 3.1 DESIGN CRITERIA ................................................................................................. 3-1 3.2 METEOROLOGICAL DAMAGE .............................................................................. 3-19 3.3 WATER DAMAGE ................................................................................................... 3-22 3.4 SEISMIC DAMAGE ................................................................................................. 3-25 3.5 SYSTEMS AND COMPONMENTS ......................................................................... 3-45 3.5a IRRADIATION FACILITY......................................................................................... 3-57 3.5b RADIOISOTPE PRODUCTION FACILITY .............................................................. 3-94

3.6 REFERENCES

........................................................................................................ 3-107 CHAPTER 4 IRRADIATION UNIT AND RADIOISOTOPE PRODUCTION FACILITY DESCRIPTION 4a1 HETEROGENEOUS REACTOR DESCRIPTION .............................................. 4a1-1 4a2 IRRADIATION FACILITY DESCRIPTION ......................................................... 4a2-1 4a2.1

SUMMARY

DESCRIPTION ............................................................................ 4a2-2 4a2.2 SUBCRITICAL ASSEMBLY .......................................................................... 4a2-6 SHINE Medical Technologies i Rev. 0

Preliminary Safety Analysis Report Master Table of Contents 4a2.3 NEUTRON DRIVER ..................................................................................... 4a2-20 4a2.4 TARGET SOLUTION VESSEL AND LIGHT WATER POOL ............................... 4a2-26 4a2.5 IRRADIATION FACILITY BIOLOGICAL SHIELD .................................................... 4a2-32 4a2.6 NUCLEAR DESIGN................................................................................................. 4a2-37 4a2.7 THERMAL HYDRAULIC DESIGN ........................................................................... 4a2-51 4a2.8 GAS MANAGEMENT SYSTEM............................................................................... 4a2-56 4a

2.9 REFERENCES

........................................................................................................ 4a2-62 4b RADIOISOTOPE PRODUCTION FACILITY DESCRIPTION.................................. 4b-1 4b.1 FACILITY AND PROCESS DESCRIPTION ............................................................ 4b-2 4b.2 RADIOISOTOPE PRODUCTION FACILITY BIOLOGICAL SHIELD....................... 4b-13 4b.3 RADIOISOTOPE EXTRACTION SYSTEM ............................................................. 4b-18 4b.4 SPECIAL NUCLEAR MATERIAL PROCESSING AND STORAGE ........................ 4b-27 4b.5 REFERENCES ........................................................................................................ 4b-56 CHAPTER 5 COOLING SYSTEMS 5a1 HETEROGENEOUS REACTOR COOLING SYSTEMS.......................................... 5a1-1 5a2 IRRADIATION UNIT COOLING SYSTEMS............................................................. 5a2-1 5a2.1

SUMMARY

DESCRIPTION ..................................................................................... 5a2-2 5a2.2 PRIMARY COOLING SYSTEM ............................................................................... 5a2-4 5a2.3 SECONDARY COOLING SYSTEM......................................................................... 5a2-13 5a2.4 PRIMARY COOLANT CLEANUP ............................................................................ 5a2-20 5a2.5 PRIMARY COOLANT MAKEUP WATER SYSTEM ................................................ 5a2-22 5a2.6 NITROGEN-16 CONTROL ...................................................................................... 5a2-25 5a2.7 AUXILIARY SYSTEMS USING PRIMARY COOLANT............................................ 5a2-26 5a

2.8 REFERENCES

........................................................................................................ 5a2-27 5b RADIOISOTOPE PRODUCTION FACILITY COOLING SYSTEMS........................ 5b-1 CHAPTER 6 ENGINEERED SAFETY FEATURES 6a1 HETEROGENEOUS REACTOR ENGINEERED SAFETY FEATURES................ 6a1-1 6a2 IRRADIATION FACILITY ENGINEERED SAFETY FEATURES .......................... 6a2-1 6a2.1

SUMMARY

DESCRIPTION ............................................................................ 6a2-2 6a2.2 IRRADIATION FACILITY ENGINEERED SAFETY FEATURES DETAILED DESCRIPTION6a2-4 6a2.3 EMERGENCY COOLING SYSTEM ........................................................................ 6a2-10 6a2.4 IRRADIATION FACILITY ENGINEERED SAFETY FEATURES TECHNICAL SPECIFICATIONS.............................................................................. 6a2-11 6a

2.5 REFERENCES

........................................................................................................ 6a2-12 6b RADIOISOTOPE PRODUCTION FACILITY ENGINEERED SAFETY FEATURES.............................................................................................................. 6b-1 6b.1

SUMMARY

DESCRIPTION ENGINEERED SAFETY FEATURES ......................... 6b-1 6b.2 RADIOISOTOPE PRODUCTION FACILITY ENGINEERED SAFETY FEATURES.............................................................................................................. 6b-3 6b.3 NUCLEAR CRITICALITY CONTROL ...................................................................... 6b-11 6b.4 REFERENCES ............................................................................................. 6b-23 SHINE Medical Technologies ii Rev. 1

Preliminary Safety Analysis Report Master Table of Contents CHAPTER 7 INSTRUMENTATION AND CONTROL SYSTEMS 7a1 HETEROGENEOUS REACTOR INSTRUMENT & CONTROL SYSTEMS................................................................................................................ 7a1-1 7a2 IRRADIATION FACILITY INSTRUMENT & CONTROL SYSTEMS ........................ 7a2-1 7a2.1

SUMMARY

DESCRIPTION..................................................................................... 7a2-1 7a2.2 DESIGN OF INSTRUMENTATION AND CONTROL SYSTEMS ............................ 7a2-3 7a2.3 TSV PROCESS CONTROL DESCRIPTION ........................................................... 7a2-31 7a2.4 TSV REACTIVITY PROTECTION SYSTEM ........................................................... 7a2-33 7a2.5 ENGINEERED SAFETY FEATURES ACTUATION SYSTEM ................................ 7a2-37 7a2.6 CONTROL CONSOLE AND DISPLAY INFORMATION.......................................... 7a2-40 7a2.7 RADIATION MONITORING SYSTEMS................................................................... 7a2-43 7a

2.8 REFERENCES

........................................................................................................ 7a2-47 7b RADIOISOTOPE PRODUCTION FACILITY INSTRUMENT &

CONTROL SYSTEM ............................................................................................... 7b-1 7b.1

SUMMARY

DESCRIPTION..................................................................................... 7b-1 7b.2 DESIGN OF INSTRUMENTATION AND CONTROL SYSTEMS ............................ 7b-2 7b.3 PRODUCTION FACILITY PROCESS CONTROL SYSTEMS ................................ 7b-29 7b.4 ENGINEERED SAFETY FEATURE AND ALARMING............................................ 7b-31 7b.5 CONTROL CONSOLE AND DISPLAY INSTRUMENTATION ................................ 7b-35 7b.6 RADIATION MONITORING SYSTEMS................................................................... 7b-37 7b.7 REFERENCES ........................................................................................................ 7b-38 CHAPTER 8 ELECTRIC POWER SYSTEMS 8a1 HETEROGENEOUS REACTOR ELECTRICAL POWER SYSTEMS ..................... 8a1-1 8a2 IRRADIATION UNIT ELECTRICAL POWER SYSTEMS ........................................ 8a2-1 8a2.1 NORMAL ELECTRICAL POWER SYSTEMS ......................................................... 8a2-1 8a2.2 EMERGENCY ELECTRICAL POWER SYSTEMS.................................................. 8a2-9 8a2.3 IRRADIATION FACILITY ELECTRICAL POWER SYSTEMS TECHNICAL SPECIFICATIONS ............................................................................. 8a2-15 8a

2.4 REFERENCES

........................................................................................................ 8a2-16 8b RADIOISOTOPE PRODUCTION FACILITY ELECTRICAL POWER SYSTEMS ................................................................................................. 8b-1 8b.1 NORMAL ELECTRICAL POWER SYSTEMS ......................................................... 8b-1 8b.2 EMERGENCY ELECTRICAL POWER SYSTEMS.................................................. 8b-2 8b.3 RADIOISOTOPE PRODUCTION FACILITY ELECTRICAL POWER SYSTEMS TECHNICAL SPECIFICATIONS............................................. 8b-3 CHAPTER 9 AUXILIARY SYSTEMS 9a1 HETEROGENEOUS REACTOR AUXILIARY SYSTEMS ....................................... 9a1-1 9a2 IRRADIATION FACILITY AUXILIARY SYSTEMS................................................... 9a2-1 9a2.1 HEATING, VENTILATION, AND AIR CONDITIONING SYSTEMS......................... 9a2-1 9a2.2 HANDLING & STORAGE OF TARGET SOLUTION ............................................... 9a2-13 9a2.3 FIRE PROTECTION SYSTEMS AND PROGRAMS ............................................... 9a2-16 SHINE Medical Technologies iii Rev. 0

Preliminary Safety Analysis Report Master Table of Contents 9a2.4 COMMUNICATIONS SYSTEMS ............................................................................. 9a2-46 9a2.5 POSSESSION & USE OF BYPRODUCT, SOURCE AND SPECIAL NUCLEAR MATERIAL............................................................................................. 9a2-48 9a2.6 COVER GAS CONTROL IN CLOSED PRIMARY COOLANT SYSTEMS .............. 9a2-50 9a2.7 OTHER AUXILIARY SYSTEMS .............................................................................. 9a2-51 9a2.8 IRRADIATION FACILITY AUXILIARY SYSTEMS TECHNICAL SPECIFICATIONS................................................................................................... 9a2-60 9a

2.9 REFERENCES

........................................................................................................ 9a2-61 9b RADIOISOTOPE PRODUCTION FACILITY AUXILIARY SYSTEMS ..................... 9b-1 9b.1 HEATING, VENTILATION, AND AIR CONDITIONING SYSTEMS......................... 9b-1 9b.2 HANDLING & STORAGE OF TARGET SOLUTION ............................................... 9b-2 9b.3 FIRE PROTECTION SYSTEMS AND PROGRAMS ............................................... 9b-6 9b.4 COMMUNICATION SYSTEMS ............................................................................... 9b-7 9b.5 POSSESSION AND USE OF BYPRODUCT, SOURCE AND SPECIAL NUCLEAR MATERIAL............................................................................................. 9b-8 9b.6 COVER GAS CONTROL IN CLOSED PRIMARY COOLANT SYSTEMS .............. 9b-15 9b.7 OTHER AUXILIARY SYSTEMS .............................................................................. 9b-25 9b.8 RADIOISOTOPE PRODUCTION FACILITY AUXILIARY SYSTEMS TECHNICAL SPECIFICATIONS ........................................................... 9b-53 9b.6 REFERENCES ........................................................................................................ 9b-54 CHAPTER 10 EXPERIMENTAL FACILITIES 10.1

SUMMARY

DESCRIPTION..................................................................................... 10-1 CHAPTER 11 RADIATION PROTECTION PROGRAM AND WASTE MANAGEMENT 11.1 RADIATION PROTECTION..................................................................................... 11-1 11.2 RADIOACTIVE WASTE MANAGEMENT................................................................ 11-42 11.3 RESPIRATORY PROTECTION PROGRAM ........................................................... 11-57 11.4 RADIATION PROTECTION PROGRAM AND WASTE MANAGEMENT TECHNICAL SPECIFICATIONS ............................................................................. 11-59

11.5 REFERENCES

........................................................................................................ 11-60 CHAPTER 12 CONDUCT OF OPERATIONS 12.1 ORGANIZATION ..................................................................................................... 12-1 12.2 REVIEW AND AUDIT ACTIVITIES.......................................................................... 12-5 12.3 PROCEDURES ....................................................................................................... 12-7 12.4 REQUIRED ACTIONS............................................................................................. 12-8 12.5 REPORTS ............................................................................................................... 12-9 12.6 RECORDS............................................................................................................... 12-10 12.7 EMERGENCY PLANNING ...................................................................................... 12-11 12.8 SECURITY PLANNING ........................................................................................... 12-12 12.9 QUALITY ASSURANCE .......................................................................................... 12-13 12.10 OPERATOR TRAINING AND REQUALIFICATION ................................................ 12-14 SHINE Medical Technologies iv Rev. 0

Preliminary Safety Analysis Report Master Table of Contents 12.10a REACTOR OPERATOR TRAINING AND REQUALIFICATION.............................. 12-14 12.10b PRODUCTION FACILITY OPERATOR TRAINING AND REQUALIFICATION ................................................................................................ 12-15 12.11 STARTUP PLAN...................................................................................................... 12-16 12.12 VACATED................................................................................................................ 12-17 12.13 MATERIAL CONTROL AND ACCOUNTABILITY PROGRAM ................................ 12-18 12.14 REFERENCES ........................................................................................................ 12-19 APPENDIX 12A EMERGENCY PLAN...................................................................................... 12A-1 APPENDIX 12B SECURITY PLAN........................................................................................... 12B-1 APPENDIX 12C QUALITY ASSURANCE PROGRAM DESCRIPTION ................................... 12C-1 APPENDIX 12D CONDUCT OF OPERATIONS PROGRAM DESCRIPTION ......................... 12D-1 CHAPTER 13 ACCIDENT ANALYSIS 13a1 HETEROGENEOUS REACTOR ACCIDENT ANALYSIS ....................................... 13a1-1 13a2 IRRADIATION FACILITY ACCIDENT ANALYSIS................................................... 13a2-1 13a2.1 ACCIDENT-INITIATING EVENTS AND SCENARIOS ............................................ 13a2-1 13a2.2 ACCIDENT ANALYSIS AND DETERMINATION OF CONSEQUENCES .................................................................................................. 13a2-36 13a3

SUMMARY

AND CONCLUSIONS .......................................................................... 13a3-1 13a4 REFERENCES ........................................................................................................ 13a4-1 13b RADIOISOTOPE PRODUCTION FACILITY ACCIDENT ANALYSES .................... 13b-1 13b.1 RADIOISOTOPE PRODUCTION FACILITY ACCIDENT ANALYSIS METHODOLOGY .................................................................................................... 13b-1 13b.2 ANALYSES OF ACCIDENTS WITH RADIOLOGICAL CONSEQUENCES .................................................................................................. 13b-4 13b.3 ANALYSIS OF ACCIDENTS WITH HAZARDOUS CHEMICALS PRODUCED FROM LICENSED MATERIAL........................................................... 13b-37 13b.4 REFERENCES ........................................................................................................ 13b-51 CHAPTER 14 TECHNICAL SPECIFICATIONS 14a1 HETEROGENEOUS REACTOR TECHNICAL SPECIFICATIONS......................... 14a1-1 14a2 IRRADIATION FACILITY TECHNICAL SPECIFICATIONS .................................... 14a2-1 14a

2.1 INTRODUCTION

..................................................................................................... 14a2-2 14a2.2 SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS ........................... 14a2-3 14a2.3 LIMITING CONDITIONS FOR OPERATION........................................................... 14a2-4 14a2.4 SURVEILLANCE REQUIREMENTS ....................................................................... 14a2-5 14a2.5 DESIGN FEATURES............................................................................................... 14a2-6 14a2.6 ADMINISTRATIVE CONTROLS.............................................................................. 14a2-7 14a

2.7 REFERENCES

........................................................................................................ 14a2-18 14b TECHNICAL SPECIFICATIONS OF PROCESSES OUTSIDE THE IRRADIATION FACILITY......................................................................................... 14b-1 14b.1 INTRODUCTION ..................................................................................................... 14b-1 14b.2 SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS ........................... 14b-2 14b.3 LIMITING CONDITIONS FOR OPERATION........................................................... 14b-3 14b.4 SURVEILLANCE REQUIREMENTS ....................................................................... 14b-4 SHINE Medical Technologies v Rev. 1

Preliminary Safety Analysis Report Master Table of Contents 14b.5 DESIGN FEATURES............................................................................................... 14b-5 14b.6 ADMINISTRATIVE CONTROLS.............................................................................. 14b-6 14b.7 REFERENCES ........................................................................................................ 14b-7 CHAPTER 15 FINANCIAL QUALIFICATIONS 15.1 FINANCIAL ABILITY TO CONSTRUCT THE SHINE FACILITY .......................... 15-1 15.2 FINANCIAL ABILITY TO OPERATE THE SHINE FACILITY ............................... 15-3 15.3 FINANCIAL ABILITY TO DECOMMISSION THE SHINE FACILITY ..................... 15-5 15.4 FOREIGN OWNERSHIP, CONTROL, OR DOMINATION .................................. 15-6

15.5 NUCLEAR INSURANCE

AND INDEMNITY ............................................................ 15-7

15.6 REFERENCES

............................................................................................. 15-8 CHAPTER 16 OTHER LICENSE CONSIDERATIONS 16.1 PRIOR USE OF FACILITY COMPONENTS ..................................................... 16-1 16.2 MEDICAL USE OF THE FACILITY .................................................................. 16-2 CHAPTER 17 DECOMMISSIONING AND POSSESSION-ONLY LICENSE AMENDMENTS 17.1 DECOMMISSIONING.............................................................................................. 17-1 17.2 POSSESSION-ONLY LICENSE AMENDMENTS ................................................... 17-2 CHAPTER 18 HIGHLY ENRICHED TO LOW ENRICHED URANIUM CONVERSION 18.1 HIGHLY ENRICHED TO LOW ENRICHED URANIUM CONVERSION.................. 18-1 CHAPTER 19 ENVIRONMENTAL REVIEW

19.1 INTRODUCTION

OF THE ENVIRONMENTAL REPORT ....................................... 19.1-1 19.2 PROPOSED ACTION.............................................................................................. 19.2-1

19.3 DESCRIPTION

OF THE AFFECTED ENVIRONMENT .......................................... 19.3-1 19.4 IMPACTS OF PROPOSED CONSTRUCTION, OPERATIONS, AND DECOMMISSIONING.............................................................................................. 19.4-1 19.5 ALTERNATIVES...................................................................................................... 19.5-1

19.6 CONCLUSION

S ...................................................................................................... 19.6-1

19.7 REFERENCES

........................................................................................................ 19.7-1 SHINE Medical Technologies vi Rev. 0